NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

11/13/24 9:30:00 AM ET

Medical/Dental Instruments

Health Care

Get the next $NMTC alert in real time by email

EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.

Event: Q4 Investor Summit
Date: Thursday, November 21, 2024
Presentation Time: 1:30pm - 2:00pm ET
Location: https://www.webcaster4.com/Webcast/Page/3075/51590

The theme is 40 micro-cap companies with a catalyst and/or strong performance in the current market.
Take a deep dive with the best Investors in MicroCap
Live Q & A
Complimentary to Qualified Investors. Please REGISTER HERE.

About the Investor Summit

The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015.

About NeuroOne
NeuroOne Medical Technologies Corporation is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.

Contact:
Fred Rockwell
[email protected]
Investor Summit Group

NMTC IR Contact
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group - MZ North America
[email protected]
(949) 694-9594

SOURCE: NeuroOne Medical Technologies Corporation

View the original press release on accesswire.com

Get the next $NMTC alert in real time by email

Date

Price Target

Rating

Analyst

3/29/2022

$6.00 → $2.00

Buy → Hold

Craig Hallum

12/3/2021

$5.75

Buy

Alliance Global Partners

11/15/2021

$6.00

Buy

Craig-Hallum

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

Chat with this insight

Recent Analyst Ratings for $NMTC

$NMTC Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Technology Officer Mertens Steve covered exercise/tax liability with 252 shares, decreasing direct ownership by 0.15% to 173,085 units (SEC Form 4)

Business Development Director Christianson Mark covered exercise/tax liability with 90 shares, decreasing direct ownership by 0.03% to 294,079 units (SEC Form 4)

CEO and President Rosa David A covered exercise/tax liability with 2,239 shares, decreasing direct ownership by 0.20% to 1,144,247 units (SEC Form 4)

$NMTC SEC Filings

Amendment: SEC Form SCHEDULE 13G/A filed by NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Termination of a Material Definitive Agreement

NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

$NMTC Leadership Updates

Live Leadership Updates

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NeuroOne Appoints Chad Wilhelmy, as Vice President of Quality Control and Regulatory Affairs

$NMTC Press Releases

Fastest customizable press release news feed in the world

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

$NMTC Financials

Live finance-specific insights

$NMTC Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

$NMTC Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

$NMTC Large Ownership Changes

This live feed shows all institutional transactions in real time.

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Numerical Tech downgraded by Craig Hallum with a new price target

Alliance Global Partners initiated coverage on NeuroOne Medical Tech with a new price target

Craig-Hallum initiated coverage on NeuroOne Medical Tech with a new price target

Volker Christopher bought $105,000 worth of shares (75,000 units at $1.40) (SEC Form 4)

Amendment: SEC Form SC 13G/A filed by NeuroOne Medical Technologies Corporation

SEC Form SC 13G filed by NeuroOne Medical Technologies Corporation

SEC Form SC 13G filed by NeuroOne Medical Technologies Corporation

$NMTC Market Insights

Live Market Insights

NeuroOne Medical Technologies shares are trading lower. The company announced that a hospital used the OneRF Ablation System.

NeuroOne Announces First In Human Ablations Completed With OneRF Ablation System

Centers For Mdicare And Medicaid Services Grants Approval For NeuroOne's ICD-10 Procedure Code For sEEG RF Ablation

Recent Analyst Ratings for
$NMTC

$NMTC
Insider Trading

$NMTC
SEC Filings

$NMTC
Leadership Updates

$NMTC
Press Releases

$NMTC
Financials

$NMTC
Analyst Ratings

$NMTC
Insider Purchases

$NMTC
Large Ownership Changes

$NMTC
Market Insights